Professional background

Dr Jasper Morrow is a consultant neurologist specialising in Neuromuscular Diseases. He undertakes general neurology clinics at UCLH and Lister Hospital, and a speciality muscle disorders clinic at The National Hospital for Neurology and Neurosurgery (NHNN). He also leads the undergraduate neurology education programme at NHNN.

Research interests

Dr Morrow completed a PhD at the Queen Square UCL Institute on Neurology in neuromuscular imaging, and continues to be active in research of quantitative neuromuscular MRI at the Queen Square Centre for Neuromuscular Diseases. He is co-PI on a number of international grants and supervises a number of PhD students.


Kanber B, Morrow JM, Klickovic U, Wastling S, Shah S, Fratta P, McDowell AR, Hall MG, Clark CA, Muntoni F, Reilly MM, Hanna MG, Alexander DC, Yousry T, Thornton JS. Musclesense: a Trained, Artificial Neural Network for the Anatomical Segmentation of Lower Limb Magnetic Resonance Images in Neuromuscular Diseases. Neuroinformatics. 2021 Apr;19(2):379-383. 

Khoo A, McLoughlin B, Cheema S, Weil RS, Lambert C, Manji H, Zandi MS, Morrow JM. Postinfectious brainstem encephalitis associated with SARS-CoV-2. J Neurol Neurosurg Psychiatry. 2020 Sep;91(9):1013-1014. doi: 10.1136/jnnp-2020-323816. Epub 2020 Jul 7.

Jesuthasan A, Shah S, Morrow JM. Use of muscle MRI in an atypical presentation of FSHD2. BMJ Case Rep. 2020 Jun 11;13(6):e236444. doi: 10.1136/bcr-2020-236444.

Morrow JM, Sormani MP. Machine learning outperforms human experts in MRI pattern analysis of muscular dystrophies. Neurology. 2020 Mar 10;94(10):421-422.

Murphy AP, Morrow J, Dahlqvist JR, Stojkovic T, Willis TA, Sinclair CDJ, et al. Natural history of limb girdle muscular dystrophy R9 over 6 years: searching for trial endpoints. Annals of Clinical and Translational Neurology. 2019;6(6):1033–45.

Morrow JM, Evans MRB, Grider T, Sinclair CDJ, Thedens D, Shah S, Yousry TA, Hanna MG, Nopoulos P, Thornton JS, Shy ME, Reilly MM. Validation of MRC Centre MRI calf muscle fat fraction protocol as an outcome measure in CMT1A. Neurology. 2018 Aug 17. 91:e1125

Morrow JM, Sinclair CD, Fischmann A, Machado PM, Reilly MM, Yousry TA,Thornton JS, Hanna MG. MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study. Lancet Neurol. 2016 Jan;15(1):65-77.

Morrow JM, Sinclair CD, Fischmann A, Reilly MM, Hanna MG, Yousry TA, Thornton JS. Reproducibility, and age, body-weight and gender dependency of candidate skeletal muscle MRI outcome measures in healthy volunteers. Eur Radiol. 2014 Apr 20. 24:1610.